These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8707364)

  • 1. Remission with carbimazole therapy & assessment of T4 suppression test as an index of relapse in patients with Graves' disease in India.
    Goswami R; Bal CS; Gupta N; Kochupillai N
    Indian J Med Res; 1996 May; 103():272-7. PubMed ID: 8707364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
    McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
    N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of outcome in Graves' disease after carbimazole treatment.
    Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
    Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of remission after antithyroid drug treatment in Graves' disease.
    Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
    Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of thyroid stimulating antibodies after antithyroid drug treatment of Graves' disease].
    Li J; Gao H; Xu L
    Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):218-20, 254-5. PubMed ID: 7922762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse.
    Weetman AP; Pickerill AP; Watson P; Chatterjee VK; Edwards OM
    Q J Med; 1994 Jun; 87(6):337-41. PubMed ID: 7913766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.
    Mastorakos G; Doufas AG; Mantzos E; Mantzos J; Koutras DA
    J Endocrinol Invest; 2003 Oct; 26(10):979-84. PubMed ID: 14759070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once daily, low dose, short term antithyroid drug treatment of Graves' disease is followed by an unacceptably high relapse rate.
    Ford HC; Feek CM; Delahunt JW
    N Z Med J; 1991 Mar; 104(907):97-8. PubMed ID: 2006072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with carbimazole in the drug treatment of the hyperthyroidism of Graves' diseases in Nigerians.
    Modebe O
    East Afr Med J; 1992 Mar; 69(3):153-6. PubMed ID: 1505405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical epidemiology of Basedow's disease in Belgium].
    Glinoer D
    Rev Med Brux; 2000 Sep; 21(4):A296-9. PubMed ID: 11068483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Graves' disease after antithyroid drug treatment in Taiwan.
    Wang PW; Liu RT; Tung SC; Chien WY; Lu YC; Chen CH; Kuo MC; Hsieh JR; Wang ST
    J Formos Med Assoc; 1998 Sep; 97(9):619-25. PubMed ID: 9795530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
    Modebe O
    Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole.
    Grebe SK; Feek CM; Ford HC; Fagerström JN; Cordwell DP; Delahunt JW; Toomath RJ
    Clin Endocrinol (Oxf); 1998 May; 48(5):585-92. PubMed ID: 9666870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype.
    Allannic H; Fauchet R; Lorcy Y; Gueguen M; Le Guerrier AM; Genetet B
    J Clin Endocrinol Metab; 1983 Oct; 57(4):719-22. PubMed ID: 6688428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism.
    Abbara A; Clarke SA; Brewster R; Simonnard A; Eng PC; Phylactou M; Papadopoulou D; Izzi-Engbeaya C; Sam AH; Wernig F; Jonauskyte E; Comninos AN; Meeran K; Kelsey TW; Dhillo WS
    Front Endocrinol (Lausanne); 2020; 11():286. PubMed ID: 32477269
    [No Abstract]   [Full Text] [Related]  

  • 18. The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
    Kim YA; Cho SW; Choi HS; Moon S; Moon JH; Kim KW; Park DJ; Yi KH; Park YJ; Cho BY
    Thyroid; 2017 Apr; 27(4):491-496. PubMed ID: 28001121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.
    Teng CS; Yeung RT
    J Clin Endocrinol Metab; 1980 Jan; 50(1):144-7. PubMed ID: 6892512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy.
    Jaffiol C; Baldet L; Robin M; Papachristou C; Lapinski H; Mirouze J
    Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.